SeaSpine Holdings

SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CARLSBAD, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch and subsequent first case of its Admiral ACP System. Admiral ACP represents the next generation of anterior cervical plating designed to strike the optimal balance between strength, profile and construct rigidity. Differentiated plate features combined with step-eliminating, innovative instrumentation work seamlessly in the surgeon's hands to create a more efficient and consistent anterior cervical discectomy and fusion (ACDF) experience.

SeaSpine Announces Limited Commercial Launch of its Admiral™ ACP System

SeaSpine Holdings Corporation (SPNE) CEO Keith Valentine on Q3 2020 Results - Earnings Call Transcript

CARLSBAD, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced financial results for the three-months ended September 30, 2020.

SeaSpine Reports Third Quarter 2020 Financial Results

CARLSBAD, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in three upcoming virtual investor conferences.

SeaSpine to Participate in Three Upcoming Investor Conferences

Study shows cells in cellular bone matrix products did not improve fusion SeaSpine's DBM outperformed the tested CBM products Study shows cells in cellular bone matrix products did not improve fusion SeaSpine's DBM outperformed the tested CBM products

SeaSpine Announces Publication of Results from a Cellular Bone Graft Study in The Journal of Bone and Joint Surgery (JBJS)

SeaSpine (SPNE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SeaSpine Holdings (SPNE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

CARLSBAD, Calif., Oct. 27, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release third quarter financial results after the close of trading on Monday, November 9, 2020. Members of the Company's management will host a corresponding conference call and webcast beginning at 1:30 pm PT / 4:30 pm ET.

SeaSpine to Report Third Quarter 2020 Financial Results on November 9, 2020

CARLSBAD, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the following four abstracts involving its products will be presented at scientific podium presentations at the NASS (North American Spine Society) 2020 Annual Meeting, which will be held virtually. Two of the abstracts received the “Best Paper” designation. The NASS 2020 Scientific Program Committee received a total of 1,234 abstracts, of which the 23 highest-rated abstracts earned the “Best Paper” designation and will be presented throughout the virtual meeting (presentation information is below).

SeaSpine Research to Feature at Multiple NASS Podium Presentations

CARLSBAD, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the third quarter of 2020 and provided a revenue outlook for the fourth quarter of 2020. The Company announced preliminary third quarter results assuming interested individuals would be focused on the U.S. presidential election the week of November 3 and plans to disclose its full third quarter financial results the week of November 9.

SeaSpine Provides Preliminary Results for Third Quarter 2020 and Revenue Guidance for Fourth Quarter 2020

Does SeaSpine Holdings (SPNE) have what it takes to be a top stock pick for momentum investors? Let's find out.

What Makes SeaSpine Holdings (SPNE) a Strong Momentum Stock: Buy Now?

As of late, it has definitely been a great time to be an investor in SeaSpine.

SeaSpine's Shares March Higher, Can It Continue?

SeaSpine Holdings is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Moving Average Crossover Alert: SeaSpine Holdings

CARLSBAD, Calif., Sept.  23, 2020  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its WaveForm C Interbody Implant System. WaveForm C represents the first of five 3D-printed interbody devices that the Company anticipates launching by mid-2021. This first limited launch marks the one-year anniversary of the SeaSpine and restor3d exclusive field-based licensing agreement.

SeaSpine Announces Limited Commercial Launch of WaveForm C 3D-Printed Interbody Implant System

CARLSBAD, Calif., Aug.  27, 2020  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will present at the Wells Fargo Securities Healthcare Conference on Thursday, September 10, 2020, beginning at 2:00 pm ET.

SeaSpine will Participate in the Wells Fargo Securities Healthcare Conference

CARLSBAD, Calif., Aug.  27, 2020  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Shoreline RT Cervical Interbody Implant System. Shoreline RT describes a series of products that enhance NanoMetalene® technology with the Company’s proprietary Reef Topography™.

SeaSpine Announces Full Commercial Launch of the Shoreline RT® Cervical Interbody Implant System

CARLSBAD, Calif., Aug.  11, 2020  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of the Explorer™ TO System.

SeaSpine® Announces Limited Commercial Launch of Explorer™ TO Expandable Interbody Device

SeaSpine Holdings Corporation (SPNE) CEO Keith Valentine on Q2 2020 Results - Earnings Call Transcript

CARLSBAD, Calif., Aug.  04, 2020  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced financial results for the three months ended June 30, 2020.

SeaSpine Reports Second Quarter 2020 Financial Results

CARLSBAD, Calif., Aug.  03, 2020  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in a virtual fireside chat at The Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13, 2020, beginning at 2:00 pm ET.  

SeaSpine to Participate in Virtual Fireside Chat  at Canaccord Genuity 40th Annual Growth Conference

SeaSpine (SPNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate SeaSpine Holdings (SPNE) to Report a Decline in Earnings: What to Look Out for

CARLSBAD, Calif., July  22, 2020  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release second quarter financial results after the close of trading on Tuesday, August 4, 2020. Members of the Company’s management will host a corresponding conference call and webcast beginning at 2:30 pm PT / 5:30 pm ET.

SeaSpine to Report Second Quarter 2020 Financial Results on August 4, 2020

CARLSBAD, Calif., June  30, 2020  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launches of Mariner MIS and Mariner Outrigger.

SeaSpine Announces Full Commercial Launch of Mariner MIS and Mariner Outrigger Spinal Fixation Systems

CARLSBAD, Calif., June  22, 2020  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launches and completion of initial surgeries of both its NorthStar OCT and Cervical Facet Fusion systems, which significantly expand its procedural offerings for posterior cervical fusion.

SeaSpine Announces Limited Commercial Launches of NorthStar™ OCT and Cervical Facet Fusion™ Systems

SeaSpine Holdings Corporation (SPNE) CEO Keith Valentine on Q1 2020 Results - Earnings Call Transcript

CARLSBAD, Calif., May  11, 2020  (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in a virtual fireside chat with BTIG.

News for SeaSpine Holdings Stock (SPNE)